Peak6 Investments LLC Bei Gene, Ltd. Call Options Transaction History

Peak6 Investments LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$178.3 - $266.78 $106,980 - $160,067	-600 Reduced 60.0%	400 $71,000
Q1 2023 May 12, 2023	BUY	$215.53 - $274.5 $215,530 - $274,500	1,000 New	1,000 $215,000
Q4 2020 Feb 12, 2021	SELL	$221.31 - $316.61 $752,454 - $1.08 Million	-3,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $643,212 - $973,896	3,400 New	3,400 $973,000

253

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.